Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice

Bai, 2001, Intra- and interstrain differences in models of “behavioral despair”, Pharmacol. Biochem. Behav., 70, 187, 10.1016/S0091-3057(01)00599-8 Barañano, 2001, Atypical neural messengers, Trends Neurosci., 24, 99, 10.1016/S0166-2236(00)01716-1 Borsini, 1988, Is the forced swimming test a suitable model for revealing antidepressant activity?, Psychopharmacology, 94, 147, 10.1007/BF00176837 Choi, 1998, Zinc and brain injury, Annu. Rev. Neurosci., 21, 347, 10.1146/annurev.neuro.21.1.347 Choi, 2001, Three pairs of cysteine residues mediate both redox and Zn2+ modulation of the NMDA receptor, J. Neurosci., 21, 392, 10.1523/JNEUROSCI.21-02-00392.2001 Christine, 1990, Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons, J. Neurosci., 10, 108, 10.1523/JNEUROSCI.10-01-00108.1990 Contestabile, 2000, Roles of NMDA receptor activity and nitric oxide production in brain development, Brain Res. Rev., 32, 476, 10.1016/S0165-0173(00)00018-7 Da Silva, 2000, Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice, Neuroreport, 11, 3699, 10.1097/00001756-200011270-00022 Eckeli, 2000, Acute treatments with GMP produce antidepressant-like effects in mice, Neuroreport, 11, 839, 10.1097/00001756-200006260-00008 Gozlan, 1995, NMDA receptor redox sites: are they targets for selective neuronal protection?, Trends Pharmacol. Sci., 16, 368, 10.1016/S0165-6147(00)89077-X Gulley, 1999, Modulatory effect of ascorbate, alone or with haloperidol, on a lever-released conditioned avoidance response task, Pharmacol. Biochem. Behav., 63, 125, 10.1016/S0091-3057(98)00249-4 Harkin, 1999, Nitric oxide synthase inhibitors have antidepressant-like properties in mice 1. Acute treatments are active in the forced swim test, Eur. J. Pharmacol., 372, 207, 10.1016/S0014-2999(99)00191-0 Javitt, 1989, Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-d-aspartate receptor channels, Mol. Pharmacol., 35, 387 Kroczka, 2000, Zinc exhibits an antidepressant-like effect in the forced swimming test in mice, Pol. J. Pharmacol., 52, 403 Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Res. Bull., 55, 297, 10.1016/S0361-9230(01)00473-7 Maes, 1994, Hypozincemia in depression, J. Affect. Disord., 31, 135, 10.1016/0165-0327(94)90117-1 Maes, 1997, Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune-inflammatory response in that illness, Biol. Psychiatry, 42, 349, 10.1016/S0006-3223(96)00365-4 Maes, 1999, Lower serum zinc in major depression in relation to changes in serum acute phase proteins, J. Affect. Disord., 56, 189, 10.1016/S0165-0327(99)00011-7 Majewska, 1990, Ascorbic acid protects neurons from injury produced by glutamate and NMDA, Neuroreport, 1, 194, 10.1097/00001756-199011000-00004 Majewska, 1990, Regulation of NMDA receptors by redox phenomena: inhibitory role of ascorbate, Brain Res., 537, 328, 10.1016/0006-8993(90)90379-P Malcon, 1997, GMP protects against quinolinic acid-induced loss of NADPH-diaphorese-positive cells in the rat striatum, Neurosci. Lett., 225, 145, 10.1016/S0304-3940(97)00225-5 McLoughlin, 1990, Zinc in depressive disorder, Acta Psychiatr. Scand, 82, 451, 10.1111/j.1600-0447.1990.tb03077.x Mittal, 1995, Interaction of heavy metal toxicants with brain constitutive nitric oxide synthase, Mol. Cell Biochem., 149-150, 263, 10.1007/BF01076586 Narang, 1991, Levels of copper and zinc in depression, Indian J. Physiol. Pharmacol., 35, 272 Nowak, 1999, Alterations in serum and brain trace element levels after antidepressant treatment. Part I. Zinc, Biol. Trace Elem., 67, 85, 10.1007/BF02784278 Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch Int. Pharm. Ther., 229, 327 Regner, 1998, Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia, Neurochem. Res., 23, 519, 10.1023/A:1022430501454 Rodrigues, 1996, Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks, Pharmacol. Toxicol., 79, 150, 10.1111/j.1600-0773.1996.tb00259.x Rice, 2000, Ascorbate regulation and its neuroprotective role in the brain, Trends Neurosci., 23, 209, 10.1016/S0166-2236(99)01543-X Schmidt, 2000, Guanosine and GMP prevents seizures induced by quinolinic acid in mice, Brain Res., 864, 40, 10.1016/S0006-8993(00)02106-5 Skolnick, 1999, Antidepressants for the new millennium, Eur. J. Pharmacol., 375, 31, 10.1016/S0014-2999(99)00330-1 Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Szewczyk, 2001, Rise in zinc affinity for the NMDA receptor evoked by chronic imipramine is species-specific, Pol. J. Pharmacol., 53, 641 Terse, 1997, Modulation a competitive N-methyl-d-aspartate receptor antagonist binding by zinc oxide, Brain Res., 744, 347, 10.1016/S0006-8993(96)01204-8 Thierry, 1986, The tail suspension test: ethical considerations, Psychopharmacology, 90, 284, 10.1007/BF00181261 Willner, 1984, The validity of animal models of depression, Psychopharmacology, 83, 1, 10.1007/BF00427414 Yildiz, 2000, Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats, Psychopharmacology, 149, 41, 10.1007/s002139900316 Zomkowski, 2002, Agmatine produces antidepressant-like effects in two models of depression in mice, Neuroreport, 13, 387, 10.1097/00001756-200203250-00005